INSTITUTE OF VIROLOGY SLOVAK ACADEMY OF SCIENCES

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10196
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5162
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
  
 
C07K PEPTIDES 4132
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8759493 MN gene and proteinOct 30, 07Jun 24, 14[A61K, C12P, C12N, C07K]
8025865 CA IX-specific inhibitorsOct 30, 07Sep 27, 11[A61K]
7910691 MN gene and proteinOct 30, 07Mar 22, 11[C07K]
7851455 MN gene and proteinOct 31, 07Dec 14, 10[A61K]
7838240 MN/CA IX/CA9 and renal cancer prognosisJan 22, 09Nov 23, 10[C12Q, G01N]
7833514 CA IX-specific inhibitorsOct 30, 07Nov 16, 10[A01N]
7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopesOct 31, 07Nov 16, 10[G01N]
7833734 CA IX-specific inhibitorsSep 08, 05Nov 16, 10[G01N]
7833737 CA IX-specific inhibitorsOct 30, 07Nov 16, 10[G01N]
7833738 CA IX-specific inhibitorsOct 30, 07Nov 16, 10[G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8628771 CA IX-specific inhibitorsExpiredOct 30, 07Jan 14, 14[A61K]
2013/0209,394 MN/CA IX AND EGFR PATHWAY INHIBITIONAbandonedFeb 02, 12Aug 15, 13[A61K]
2011/0244,475 MN Gene and ProteinAbandonedOct 30, 07Oct 06, 11[G01N, C07K]
2011/0027,225 MN/CA IX and EGFR Pathway InhibitionAbandonedOct 07, 10Feb 03, 11[A61K, A61P]
2010/0297,752 MN Gene and ProteinAbandonedAug 04, 10Nov 25, 10[C12N]
2010/0080,815 MN Gene and ProteinAbandonedAug 18, 09Apr 01, 10[A61K, C07H, C12P, C12N, G01N, A61P, C07K]
2010/0056,611 MN/CA9 Splice VariantsAbandonedOct 12, 07Mar 04, 10[A61K, C07H, C12Q, C07K]
2009/0239,247 MN and HypoxiaAbandonedMar 03, 09Sep 24, 09[G01N]
2009/0118,473 MN Gene and ProteinAbandonedOct 31, 07May 07, 09[C07H, C07K]
2008/0221,309 MN Gene and ProteinAbandonedOct 31, 07Sep 11, 08[C07K]
2008/0214,787 MN Gene and ProteinAbandonedOct 31, 07Sep 04, 08[C07K]
2008/0176,268 MN Gene and ProteinAbandonedOct 31, 07Jul 24, 08[C07H, C12Q, C07K]
2008/0177,046 Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with Her-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant EpitopesAbandonedOct 31, 07Jul 24, 08[C07K]
2008/0146,780 MN Gene and ProteinAbandonedOct 30, 07Jun 19, 08[C07K]
2008/0038,251 MN/CA IX and MAPK inhibitionAbandonedMar 20, 07Feb 14, 08[A61K, C12Q, A61P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.